| |
|
|
|
THURSDAY, FEBRUARY 26, 2009 |
|
THURSDAY
MORNING
SESSION I |
SESSION 1 |
|
Jay Skyler:
Immunotherapy of Type 1 Diabetes |
|
HALL A:
SMBG – IMPACT ON DIABETIC CONTROL |
HALL B:
PATIENTS AND TECHNOLOGY |
|
Irl Hirsch:
SMBG frequency & titration guidelines for insulin treated subjects |
Lorry Laffel:
The use of new diabetes technologies in school and in the family |
|
Boris Kovatchev:
Glucose variability - clinical relevance, assessment, and control |
Gerard Reach:
Prevention of diabesity – novel approach to tackle this problem |
|
LECTURE SPONSORED BY BAYER
Stan Telson:
Information-based tools for patients using SMBG |
Deborah Christie:
Relationship between technology and motivation in children with diabetes |
|
|
Coffee Break, Exhibition and Poster Viewing |
|
THURSDAY
MORNING
SESSION 2 |
SESSION 2 – ADVANCED APPROACHES TO OBESITY AND DIABETES (HALL A) |
|
Francesco Rubino:
Mechanisms of the effect of bariatric surgical techniques on glucose metabolism. |
|
Scott Shikora:
NeuroModulation for the Treatment of Obesity and Metabolic Disorders |
|
Elizabeth Rajan:
Endoscopic interventions for obesity - present and future |
|
|
Lunch Break |
|
THURSDAY
AFTERNOON
SESSION 3 |
SESSION 3 |
|
HALL A: AIDPIT SYMPOSIUM |
HALL B: P-CEZANNE SYMPOSIUM |
|
SEVERE HYPOGLYCEMIA |
TBD |
|
Stephanie Amiel:
Definition, detection, outcome & impact |
Detailed program to be announced at a later stage |
|
Eric Renard:
Solutions offered by diabetes Technologies |
Detailed program to be announced at a later stage |
|
Marie-Christie Vantyghem:
When should islet transplantation be considered? |
Detailed program to be announced at a later stage |
|
Boris Kovatchev:
Can severe hypoglycemia be predicted and prevented? |
Detailed program to be announced at a later stage |
|
Ugo Boggi:
When should pancreas transplantation be considered? |
Detailed program to be announced at a later stage |
|
|
Coffee Break, Exhibition and Poster Viewing |
|
THURSDAY
AFTERNOON
SESSION 4 |
SESSION 4 |
|
HALL A: GLUCOSE VARIABILITY |
HALL B: CLINICAL PRACTICE |
|
Franco Chiarelli:
Role of fasting and postprandial glycemic control on the development of diabetic complications |
Natasa Ursic Bratina
The use of CSII with CGM as a treatment of choice |
|
Bruce Bode:
TBD |
TBD |
|
J. Hans DeVries:
Glycemic variability - much ado about nothing |
TBD |
|
17:00-19:30 |
COMPANIES’ WORKSHOPS |
|
HALL A |
HALL B |
|
Abbott Workshop |
DexCom Workshop
CGM: Issues that matter, outpatient use and in-hospital applications
* pre-registration is required |
|
|
|
|
|
FRIDAY, FEBRUARY 27, 2009 |
|
FRIDAY
MORNING
SESSION 5 |
SESSION 5 |
|
Michael Strano:
Near infrared glucose detection based upon implantable nanosensors |
|
HALL A:
TECHNOLOGY – HEALTH POLICY AND BENEFIT |
HALL B:
CONTINUOUS GLUCOSE MONITORING |
|
Thomas Danne:
Do we need centers of reference to implement new technologies in pediatric diabetes? |
Christos Zoupas:
Experience with Guardian and Carelink |
|
Satish Garg:
Health outcomes from CGM |
Lois Jovanovic:
Utility of continuous glucose monitoring throughout pregnancy |
|
Francine Kaufman:
Promotion of healthy lifestyle for children |
John Pickup:
Fluorescence: shedding light on glucose sensing |
|
|
Coffee Break, Exhibition and Poster Viewing |
|
10:30-12:00 |
SESSION 6 – SPONSORED SESSION – MEDTRONIC (Hall A) |
|
|
Lunch Break |
|
FRIDAY
AFTERNOON
SESSION 7 |
SESSION 7 – THE LOOP CLUB (Hall A) |
|
Bruce Buckingham:
The Stanford-UCSB-Denver progress towards a closed-loop |
|
Moshe Phillip/Eran Atlas:
The Schneider experience toward closing the loop |
|
Claudio Cobelli:
Subcutaneous model predictive control clinical trial powered by in silico studies |
|
|
Coffee Break, Exhibition and Poster Viewing |
|
15:30-17:00 |
SESSION 8 – SPONSORED SESSION - ROCHE DIAGNOSTICS GmbH (HALL A) |
|
17:15-18:45 |
SESSION 9 – SPONSORED SESSION (HALL A) |
|
|
|
|
|
SATURDAY, FEBRUARY 28, 2009 |
|
SATURDAY
MORNING
SESSION I0 |
SESSION 10 |
|
HALL A:
AIDPIT SYMPOSIUM |
HALL B: |
|
REPRODUCING INSULIN SECRETION |
ONGOING STUDIES |
|
Roman Hovorka:
Physiology of insulin secretion: what is needed for restoration |
Irl Hirsch:
Implications of the CGM Studies: where are we now? |
|
Roger Lehman:
How well do transplanted islet cells restore insulin secretion? |
Peter Chase/ Bruce Buckingham:
Pump shut off to prevent nocturnal hypoglycemia |
|
Chiara Dalla Man:
How can algorithm connecting glucose sensors to insulin deliver devices mimic insulin secretion? |
Howard Wolpert:
Issues with closing the loop – critical appraisal |
|
Paola Maffi:
How to improve islet transplantation in humans? |
Tadej Battelino:
Realistic expectations of closed-loop |
|
Udo Hoss:
Continuous glucose monitoring in the tissue. Do we really need to callibrate in-vivo? |
Revital Nimri:
TBD |
|
|
Coffee Break, Exhibition and Poster Viewing |
|
SATURDAY
MORINING
SESSION 11 |
SESSION 11 – NOVEL STRATEGIES FOR TREATMENT OF OBESITY & DIABETES (Hall A) |
|
Jay Skyler:
Peptide hormones for obesity |
|
Alfredo Genco:
Gastric balloon – clinical experience and metabolic effects |
|
|
Henry Buchwald:
Metabolic/bariatric surgery in the treatment of type 2 diabetes |
|
|
|
Lunch Break |
|
SATURDAY
AFTERNOON
SESSION 12 |
SESSION 12 – ORAL PRESENTATIONS |
|
HALL A |
HALL B |
|
|
|
|
|
|
Coffee Break, Exhibition and Poster Viewing |
|
SATURDAY
AFTERNOON
SESSION 13 |
SESSION 13 – FRONTIERS IN DIABETES TECHNOLOGIES (Hall A) |
|
Christophe De Block:
Use of continuous glucose monitoring in critical illness/ICU |
|
George Eisenbarth:
Next generation genome sequencing: implications for type 1 diabetes |
|
|
Paolo Pozzilli:
CSII to protect residual beta cell function in type 1 diabetes |
|
|
|
Closing remarks: Moshe Phillip |